Related Experiment Video
Updated: Aug 9, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Protease inhibitors block apoptosis at intermediate stages: a compared analysis of DNA fragmentation and apoptotic
L Ghibelli1, V Maresca, S Coppola
1Dipartimento di Biologia, Università di Roma Tor Vergata, Italy.
Abstract:
The possible correlation between DNA digestion and changes in nuclear morphology in apoptosis was studied by blocking the apoptotic process at intermediate stages. The apoptogenic action of three drugs: etoposide, puromycin, tributyltin, was contrasted with protease inhibitors with different specificity on U937 cells. The inhibitors interfered with the development of the apoptotic features without shifting cell death to necrosis: treated cells showed abnormal morphologies, which could be recognized as intermediate stages of apoptosis; accordingly, DNA analysis showed an inhibitor-dependent block of the apoptotic DNA digestion. The comparison between size of DNA fragments and nuclear morphology suggested the following correlations: loss of normal nuclear shape with the appearance of a > or = 2 Mb DNA band; ongoing chromatin condensation with the progressive DNA digestion up to 50 kb; nuclear fragmentation with DNA laddering. Protease inhibitors in etoposide-treated cells did not allow the formation of 700-300 kb fragments, suggesting that they possibly derive from a cell-mediated effect.
Insights
This study reveals how DNA digestion correlates with nuclear changes during apoptosis. Protease inhibitors block DNA fragmentation, offering insights into intermediate stages of programmed cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Apoptosis, or programmed cell death, involves characteristic DNA fragmentation and nuclear morphological changes.
- Understanding the precise correlation between DNA digestion and nuclear morphology is crucial for deciphering cell death pathways.
Purpose of the Study:
- To investigate the correlation between DNA digestion and nuclear morphology during apoptosis.
- To identify intermediate stages of apoptosis by blocking the process using protease inhibitors.
- To compare the effects of different apoptogenic drugs and protease inhibitors on U937 cells.
Main Methods:
- Blocking apoptosis at intermediate stages using protease inhibitors.
- Treating U937 cells with apoptogenic drugs (etoposide, puromycin, tributyltin) and protease inhibitors.
- Analyzing nuclear morphology and DNA digestion patterns using DNA analysis.
- Comparing DNA fragment sizes with observed nuclear morphologies.
Main Results:
- Protease inhibitors prevented the development of typical apoptotic features without causing necrosis.
- Abnormal nuclear morphologies were observed, representing intermediate stages of apoptosis.
- DNA analysis demonstrated an inhibitor-dependent blockade of apoptotic DNA digestion.
- Specific correlations were found: loss of nuclear shape with >2 Mb DNA band, chromatin condensation with 50 kb DNA fragments, and nuclear fragmentation with DNA laddering.
- Protease inhibitors blocked the formation of 700-300 kb fragments in etoposide-treated cells, suggesting a cell-mediated origin.
Conclusions:
- The study establishes clear correlations between specific DNA digestion patterns and nuclear morphological changes during apoptosis.
- Protease inhibitors are effective tools for dissecting intermediate stages of apoptosis and understanding DNA fragmentation.
- The findings suggest that certain DNA fragments (700-300 kb) may result from cell-mediated effects during etoposide-induced apoptosis.
Related Concept Videos
Negative Regulator Molecules
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Inhibitors of Bacterial DNA Synthesis

